Munich - Delayed Quote EUR

Biomarin Pharmaceutical Inc (BM8.MU)

Compare
61.58
+0.58
+(0.95%)
At close: January 31 at 8:00:44 AM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
414,697.00
159,259.00
175,902.00
304,536.00
85,365.00
Investing Cash Flow
-4,876.00
-111,244.00
-20,029.00
-366,313.00
-53,621.00
Financing Cash Flow
-518,466.00
-18,727.00
-18,650.00
-48.00
181,118.00
End Cash Position
676,769.00
755,127.00
724,531.00
587,276.00
649,158.00
Income Tax Paid Supplemental Data
57,713.00
73,312.00
54,372.00
18,153.00
8,977.00
Interest Paid Supplemental Data
10,317.00
10,303.00
10,281.00
10,395.00
12,178.00
Capital Expenditure
-113,815.00
-107,611.00
-131,540.00
-119,225.00
-137,519.00
Issuance of Debt
--
--
--
--
585,752.00
Repayment of Debt
-497,273.00
-2,286.00
-2,605.00
-3,039.00
-381,909.00
Repurchase of Capital Stock
--
--
--
--
-50,000.00
Free Cash Flow
300,882.00
51,648.00
44,362.00
185,311.00
-52,154.00
12/31/2020 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers